
    
      After 1 week run in period with single-blind placebo, participants meeting the inclusion and
      none of the exclusion criteria were randomized to receive double-blind treatment with either
      gabapentin enacarbil 600 mg or placebo for 12 weeks treatment period. After then,
      single-blind placebo was given for 1 week for follow-up observation.
    
  